Predictions
KWS Saat SE & Co. KGaA
Start price
Target price
Perf. (%)
€76.60
01.06.21
01.06.21
-
01.06.22
01.06.22
-18.80%
02.06.22
02.06.22
Orbital Infrastructure Group inc.
Start price
Target price
Perf. (%)
€178.40
01.06.21
01.06.21
€240.00
01.06.22
01.06.22
-6.28%
12.06.21
12.06.21
Capable Management
Could be worthwhile Investment >10% per year
Good culture
Few uniques
Vertex Energy Inc.
Start price
Target price
Perf. (%)
€8.60
01.06.21
01.06.21
€6.00
01.06.22
01.06.22
-22.09%
12.06.21
12.06.21
Capable Management
Few uniques
Probably not worthwhile Investment
Ballard Power Systems Inc.
Start price
Target price
Perf. (%)
€14.20
01.06.21
01.06.21
€23.00
01.06.22
01.06.22
-1.34%
01.06.21
01.06.21
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Encavis AG
Start price
Target price
Perf. (%)
€14.87
31.05.21
31.05.21
€17.00
31.05.22
31.05.22
1.55%
27.07.21
27.07.21
Differentiated customer and product portfolio
Standard Investments for future growth
High valuation
Higher risks for its business
VERBIO Vereinigte BioEnergie AG
Start price
Target price
Perf. (%)
€46.68
31.05.21
31.05.21
€50.00
31.05.22
31.05.22
-9.73%
28.06.21
28.06.21
Well known brand
Market Leader or Top 3
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
VERBIO Vereinigte BioEnergie AG
Start price
Target price
Perf. (%)
€46.68
31.05.21
31.05.21
€50.00
31.05.22
31.05.22
-9.73%
28.06.21
28.06.21
Well known brand
Market Leader or Top 3
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
GFT Technologies AG
Start price
Target price
Perf. (%)
€20.55
31.05.21
31.05.21
€12.00
31.05.22
31.05.22
76.40%
28.11.21
28.11.21
Risky Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Low dividend yield expected
Sangamo Therapeutics Inc.
Start price
Target price
Perf. (%)
€8.74
31.05.21
31.05.21
€15.00
31.05.22
31.05.22
-60.61%
01.06.22
01.06.22
Fair valuation
Strong uniques
Leading role in innovation
Bad rating
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€2.18
31.05.21
31.05.21
€4.00
31.05.22
31.05.22
4.59%
14.06.21
14.06.21
Could be worthwhile Investment >10% per year
Ziopharm Oncology
Start price
Target price
Perf. (%)
€2.44
31.05.21
31.05.21
€4.00
31.05.22
31.05.22
-2.46%
07.06.21
07.06.21
Could be worthwhile Investment >10% per year
Molecular Templates Inc.
Start price
Target price
Perf. (%)
€7.24
31.05.21
31.05.21
€12.00
31.05.22
31.05.22
0.62%
14.06.21
14.06.21
Could be very worthwhile Investment >20% year
Wabtec Corp.
Start price
Target price
Perf. (%)
€67.24
30.05.21
30.05.21
-
30.05.22
30.05.22
15.23%
08.10.21
08.10.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Low dividend yield expected
Airbnb Inc.
Start price
Target price
Perf. (%)
€117.00
30.05.21
30.05.21
€114.00
30.05.22
30.05.22
-0.84%
31.05.22
31.05.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Twitter Inc.
Start price
Target price
Perf. (%)
€47.71
29.05.21
29.05.21
-
29.05.22
29.05.22
-17.57%
21.12.21
21.12.21
Revenue growth >5% per year expected
Stable Large shareholder and/or long term investor
Very low/no dividend yield expected
Delivery Hero SE
Start price
Target price
Perf. (%)
€111.10
29.05.21
29.05.21
€80.00
29.05.22
29.05.22
-69.15%
30.05.22
30.05.22
Risky Investment
overvalued
Bad rating
Increased challenges to pay loans and raise capital
Adverum Biotechnologies Inc.
Start price
Target price
Perf. (%)
€2.86
29.05.21
29.05.21
-
29.05.22
29.05.22
-71.59%
30.05.22
30.05.22
Could be very worthwhile Investment >20% year
